(Q41589794)

4 October 2017

1 reference

title

Unmet therapeutic needs in the management of acute ischemia (English)

1 reference

4 October 2017

H D White

1

1 reference

4 October 2017

language of work or name

English

0 references

publication date

1 August 1997

1 reference

American Journal of Cardiology

4 October 2017

published in

1 reference

4 October 2017

volume

80

1 reference

4 October 2017

issue

4A

1 reference

4 October 2017

page(s)

2B-10B

1 reference

New insights into the pathogenesis, prevention and management of acute coronary syndromes

4 October 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2900571-7

Prospective evaluation of eligibility for thrombolytic therapy in acute myocardial infarction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2900571-7

Recognition and treatment of unstable angina

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2900571-7

Diagnosing and managing unstable angina. Agency for Health Care Policy and Research

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2900571-7

Percutaneous transluminal coronary angioplasty

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2900571-7

Lewis A. Conner Memorial Lecture. Mechanisms leading to myocardial infarction: insights from studies of vascular biology

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2900571-7

Effectiveness of revascularization in the Emory angioplasty versus surgery trial. A randomized comparison of coronary angioplasty with bypass surgery

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2900571-7

Angioplasty versus bypass surgery

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2900571-7

Comparison of coronary bypass surgery with angioplasty in patients with multivessel disease. The Bypass Angioplasty Revascularization Investigation (BARI) Investigators

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2900571-7

Coronary stent occlusion: thrombus horribilis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2900571-7

Indications for fibrinolytic therapy in suspected acute myocardial infarction: collaborative overview of early mortality and major morbidity results from all randomised trials of more than 1000 patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2900571-7

Fibrin-selective thrombolytic therapy for acute myocardial infarction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2900571-7

The effects of tissue plasminogen activator, streptokinase, or both on coronary-artery patency, ventricular function, and survival after acute myocardial infarction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2900571-7

Antiplatelet and anticoagulant use after myocardial infarction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2900571-7

Combination antithrombotic therapy in unstable rest angina and non-Q-wave infarction in nonprior aspirin users. Primary end points analysis from the ATACS trial. Antithrombotic Therapy in Acute Coronary Syndromes Research Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2900571-7

Adding heparin to aspirin reduces the incidence of myocardial infarction and death in patients with unstable angina. A meta-analysis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2900571-7

Issues Regarding the Use of Heparin Following Streptokinase Therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2900571-7

Platelet glycoprotein IIb/IIIa receptor antagonists in coronary artery disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2900571-7

Novel antiplatelet therapies for treatment of patients with ischemic heart disease: inhibitors of the platelet glycoprotein IIb/IIIa integrin receptor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2900571-7

Platelet glycoprotein IIb/IIIa receptors in cardiovascular medicine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2900571-7

Use of a monoclonal antibody directed against the platelet glycoprotein IIb/IIIa receptor in high-risk coronary angioplasty

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2900571-7

Risk of thrombosis in human atherosclerotic plaques: role of extracellular lipid, macrophage, and smooth muscle cell content

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2900571-7

Determinants of collateral filling observed during sudden controlled coronary artery occlusion in human subjects

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2900571-7

Influence of coronary collateral vessels on myocardial infarct size in humans. Results of phase I thrombolysis in myocardial infarction (TIMI) trial. The TIMI Investigators

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2900571-7

Morphologic comparison of frequency and types of acute lesions in the major epicardial coronary arteries in unstable angina pectoris, sudden coronary death and acute myocardial infarction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2900571-7

Influence of plaque configuration and stress distribution on fissuring of coronary atherosclerotic plaques

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2900571-7

Morphodynamic interpretation of acute coronary thrombosis, with special reference to volcano-like eruption of atheromatous plaque caused by coronary artery spasm

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2900571-7

Progression of coronary atherosclerosis: is coronary spasm related to progression?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2900571-7

Plaque fissuring--the cause of acute myocardial infarction, sudden ischaemic death, and crescendo angina

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2900571-7

Angiographic evolution of coronary artery morphology in unstable angina

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2900571-7

Correlation of coronary angioscopic to angiographic findings in coronary artery disease.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2900571-7

The role of intracoronary thrombus in unstable angina: angiographic assessment and thrombolytic therapy during ongoing anginal attacks

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2900571-7

Incomplete lysis of thrombus in the moderate underlying atherosclerotic lesion during intracoronary infusion of streptokinase for acute myocardial infarction: quantitative angiographic observations

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2900571-7

Angiographic progression of coronary artery disease and the development of myocardial infarction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2900571-7

Angioscopic Evaluation of Coronary-Artery Thrombi in Acute Coronary Syndromes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2900571-7

Coronary thrombosis and platelet/fibrin microemboli in death associated with acute myocardial infarction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2900571-7

Late assessment of thrombolytic efficacy (LATE) study: Prognosis in patients with non-Q wave myocardial infarction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2900571-7

Non-Q wave and ST segment depression myocardial infarction: is there a role for thrombolytic therapy?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2900571-7

One-year results of the Thrombolysis in Myocardial Infarction (TIMI) IIIB clinical trial. A randomized comparison of tissue-type plasminogen activator versus placebo and early invasive versus early conservative strategies in unstable angina and non-

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2900571-7

Aspirin, heparin, or both to treat acute unstable angina

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2900571-7

Collaborative overview of randomised trials of antiplatelet therapy--I: Prevention of death, myocardial infarction, and stroke by prolonged antiplatelet therapy in various categories of patients. Antiplatelet Trialists' Collaboration

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2900571-7

Early clinical experience with integrelin, an inhibitor of the platelet glycoprotein IIb/IIIa integrin receptor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2900571-7

Profound inhibition of platelet aggregation with monoclonal antibody 7E3 Fab after thrombolytic therapy. Results of the Thrombolysis and Angioplasty in Myocardial Infarction (TAMI) 8 Pilot Study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2900571-7

Abciximab (c7E3 Fab). A review of its pharmacology and therapeutic potential in ischaemic heart disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2900571-7

Pharmacodynamics of chimeric glycoprotein IIb/IIIa integrin antiplatelet antibody Fab 7E3 in high-risk coronary angioplasty.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2900571-7

ABCIXIMAB: a new antiaggregant used in angioplasty

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2900571-7

Monoclonal antibodies to platelet glycoprotein IIb/IIIa as antithrombotic agents

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2900571-7

Randomised trial of coronary intervention with antibody against platelet IIb/IIIa iritegrin for reduction of clinical restenosis: results at six months

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2900571-7

Platelet glycoprotein IIb/IIIa receptor blockade and low-dose heparin during percutaneous coronary revascularization

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2900571-7

10.1016/S0002-9149(97)00571-7

7 January 2021

Identifiers

DOI

1 reference

4 October 2017

1 reference